Kyungmi Kim
Korea University · 生化学・遺伝学・分子生物学
研究室紹介
Professor Kyungmi Kim's research lab specializes in translational biomedical research, focusing on the development of non-invasive biomarkers for early cancer detection using metabolomics, particularly in renal cell carcinoma. The lab also pioneers innovative genome-editing technologies, including CRISPR-Cas9 and prime editing, for modeling genetic diseases and therapeutic applications in conditions such as age-related macular degeneration. A key emphasis is on optimizing precision genome editing tools for improved efficiency and safety in preclinical models. Additionally, the lab explores behavioral and psychological aspects of consumer decision-making in response to pricing strategies, integrating social science with health and behavioral research.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15Renal cell carcinoma (RCC) accounts for 11,000 deaths per year in the United States. When detected early, generally serendipitously by imaging conducted for other reasons, long term survival is generally excellent. When detected with symptoms, prognosis is poor. Under these circumstances, a screening biomarker has the potential for substantial public health benefit. The purpose of this study was to evaluate the utility of urine metabolomics analysis for metabolomic profiling, identification of b
RNA-guided genome surgery using CRISPR-Cas9 nucleases has shown promise for the treatment of diverse genetic diseases. Yet, the potential of such nucleases for therapeutic applications in nongenetic diseases is largely unexplored. Here, we focus on age-related macular degeneration (AMD), a leading cause of blindness in adults, which is associated with retinal overexpression of, rather than mutations in, the VEGFA gene. Subretinal injection of preassembled, Vegfa gene–specific Cas9 ribonucleoprot
Kidney cancer is the seventh most common cancer in the Western world, its incidence is increasing, and it is frequently metastatic at presentation, at which stage patient survival statistics are grim. In addition, there are no useful biofluid markers for this disease, such that diagnosis is dependent on imaging techniques that are not generally used for screening. In the present study, we use metabolomics techniques to identify metabolites in kidney cancer patients' urine, which appear at differ
Prime editors, novel genome-editing tools consisting of a CRISPR-Cas9 nickase and an engineered reverse transcriptase, can induce targeted mutagenesis. Nevertheless, much effort is required to optimize and improve the efficiency of prime-editing. Herein, we introduce two strategies to improve the editing efficiency using proximal dead sgRNA and chromatin-modulating peptides. We used enhanced prime-editing to generate Igf2 mutant mice with editing frequencies of up to 47% and observed germline tr
Genetically engineered animal models that reproduce human diseases are very important for the pathological study of various conditions. The development of the clustered regularly interspaced short palindromic repeats (CRISPR) system has enabled a faster and cheaper production of animal models compared with traditional gene-targeting methods using embryonic stem cells. Genome editing tools based on the CRISPR-Cas9 system are a breakthrough technology that allows the precise introduction of mutati
본 연구는 조절초점이 다른 소비자들이 최대가격 및 최소가격 할인광고에 대하여 어떻게 반응하는지 고찰하였다. 실험결과, 먼저 기존연구에서 보고된 바와 같이, 최소가격 할인광고보다는 최대가격 할인광고를 실시한 소매점에 대하여 소비자들은 전반적으로 절약을 더 많이 할 수 있을 것이라 지각하였고, 거래의 가치를 더 크게 평가하였으며, 보다 우호적인 거래태도를 보였고, 구매하려는 의향을 더 지닌 것으로 밝혀졌다. 하지만, 동일한 가격할인 광고에 대한 반응은 소비자의 조절초점에 따라서 다르게 나타났다. 즉, 이상을 추구하고 모험적인 특성을 가진 향상초점 소비자들은 보수적이고 위험에 민감하며 안전을 중시하는 방어초점 소비자들보다 최대가격 할인광고에 더욱 긍정적으로 반응하였다. 반면, 최소가격 할인광고의 경우 방어초점 소비자들이 더욱 우호적으로 평가하였다. 이러한 조절초점의 차별적 효과는 가격할인의 준거로서 경쟁자가격이 사용되었을 때에는 명확하게 나타났지만, 과거가격이 준거로 사용된 광고에서는 나
Mitochondria are of fundamental importance in programmed cell death, cellular metabolism, and intracellular calcium concentration modulation, and inheritable mitochondrial disorders via mitochondrial DNA (mtDNA) mutation cause several diseases in various organs and systems. Nevertheless, mtDNA editing, which plays an essential role in the treatment of mitochondrial disorders, still faces several challenges. Recently, programmable editing tools for mtDNA base editing, such as cytosine base editor
Transformed, hybrid Saccharomyces strains capable of simultaneous secretion of glucoamylase and alpha-amylase have been produced. These strains could carry out direct, one-step assimilation of starch, with conversion efficiency greater than 93% during a 5-day growth period. One of the transformants converted 92.8% of available starch into reducing sugars in only 2 days. Glucoamylase secretion by these strains resulted from expression of one or more chromosomal STA genes derived from Saccharomyce
The CRISPR-Cas system stands out as a promising genome editing tool due to its cost-effectiveness and time efficiency compared to other methods. This system has tremendous potential for treating various diseases, including genetic disorders and cancer, and promotes therapeutic research for a wide range of genetic diseases. Additionally, the CRISPR-Cas system simplifies the generation of animal models, offering a more accessible alternative to traditional methods. The CRISPR-Cas9 system can be us
Mitochondria are subcontractors dedicated to energy production within cells. In human mitochondria, almost all mitochondrial proteins originate from the nucleus, except for 13 subunit proteins that make up the crucial system required to perform 'oxidative phosphorylation (OX PHOS)', which are expressed by the mitochondria's self-contained DNA. Mitochondrial DNA (mtDNA) also encodes 2 rRNA and 22 tRNA species. Mitochondrial DNA replicates almost autonomously, independent of the nucleus, and its h